Compare, Analyse Novartis with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs MYLAN (US) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   MYLAN
EQUITY SHARE DATA
    NOVARTIS
Mar-19
MYLAN
Dec-18
NOVARTIS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs9803,478-   
Low Rs6001,914-   
Sales per share (Unadj.) Rs198.71,600.4-  
Earnings per share (Unadj.) Rs21.043.5-  
Cash flow per share (Unadj.) Rs22.3343.1-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.51,731.4-  
Shares outstanding (eoy) m24.69514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.7 236.0%   
Avg P/E ratio x37.762.0 60.7%  
P/CF ratio (eoy) x35.57.9 451.8%  
Price / Book Value ratio x2.61.6 165.0%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5081,387,238 1.4%   
No. of employees `0000.635.0 1.7%   
Total wages/salary Rs m1,1710-   
Avg. sales/employee Rs Th8,445.423,526.5 35.9%   
Avg. wages/employee Rs Th2,015.70-   
Avg. net profit/employee Rs Th891.0638.8 139.5%   
INCOME DATA
Net Sales Rs m4,907823,426 0.6%  
Other income Rs m7830-   
Total revenues Rs m5,689823,426 0.7%   
Gross profit Rs m123213,072 0.1%  
Depreciation Rs m32154,178 0.0%   
Interest Rs m1639,604 0.0%   
Profit before tax Rs m85819,290 4.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340-3,069 -11.1%   
Profit after tax Rs m51822,359 2.3%  
Gross profit margin %2.525.9 9.7%  
Effective tax rate %39.6-15.9 -249.2%   
Net profit margin %10.62.7 388.5%  
BALANCE SHEET DATA
Current assets Rs m8,055459,800 1.8%   
Current liabilities Rs m1,850335,245 0.6%   
Net working cap to sales %126.415.1 835.9%  
Current ratio x4.41.4 317.4%  
Inventory Days Days4584 53.9%  
Debtors Days Days3493 36.3%  
Net fixed assets Rs m150159,731 0.1%   
Share capital Rs m123438 28.1%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,592890,796 0.9%   
Long term debt Rs m0961,455 0.0%   
Total assets Rs m9,8242,389,462 0.4%  
Interest coverage x54.91.5 3,694.7%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.50.3 144.9%   
Return on assets %5.42.6 209.4%  
Return on equity %6.82.5 271.7%  
Return on capital %11.53.2 361.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,943171,108 -1.1%  
From Investments Rs m2,742-88,444 -3.1%  
From Financial Activity Rs m-298-79,712 0.4%  
Net Cashflow Rs m5011,418 35.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.07 Rs / USD

Compare NOVARTIS With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: ALKEM LABORATORIES  TORRENT PHARMA  PANACEA BIOTECH  WOCKHARDT  BIOCON   



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


Feb 26, 2021 03:36 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - GSK PHARMA COMPARISON

COMPARE NOVARTIS WITH

FEATURED VIDEOS

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

More Featured Videos

MARKET STATS